BIOGAIA AB
50Patents
38Active
50Granted
50Portfolio score
Filing activity: Mar 18, 1991 → May 20, 2022 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5413960A | Antibiotic reuterin | Chemistry; Metallurgy | 54 | Expired |
| US6786330B2 | Two-compartment container | Performing Operations; Transporting | 51 | Expired |
| US6513650B2 | Two-compartment container | Human Necessities | 50 | Expired |
| US5534253A | Method of treating enteropathogenic bacterial infections in poultry | Human Necessities | 35 | Expired |
| US6769539B2 | Device for protecting and adding a component to a container | Human Necessities | 17 | Expired |
| US5458875A | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry | Human Necessities | 16 | Expired |
| US5352586A | Method of determining the presence of an antibiotic produced by Lactobacillus reuteri | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5480641A | Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6454088B2 | Two-compartment package | Performing Operations; Transporting | 8 | Expired |
| US6872565B2 | Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7374924B2 | Use of selected lactic acid bacteria for reducing infantile colic | Emerging Cross-Sectional Technologies | 6 | Active |
| US7910127B2 | Use of lactic acid bacteria for improving food lysine absorption of pet animals | Human Necessities | 3 | Active |
| US8016104B2 | Two-compartment container having depressible flexible dome for rupturing layer between compartments | Emerging Cross-Sectional Technologies | 2 | Active |
| US10004770B2 | Production and use of bacterial histamine | Physics | 2 | Active |
| US7105336B2 | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter | Chemistry; Metallurgy | 1 | Expired |
| US9340840B2 | Use of selected lactic acid bacteria for reducing infantile colic | Emerging Cross-Sectional Technologies | 1 | Active |
| US9351512B2 | Active plastic material in oil | Performing Operations; Transporting | 1 | Active |
| US9057112B2 | Use of selected lactic acid bacteria for reducing infantile colic | Emerging Cross-Sectional Technologies | 1 | Active |
| US7678553B2 | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter | Chemistry; Metallurgy | 1 | Active |
| US11602551B2 | Use of inosine for the treatment of t-reg deficiency | Human Necessities | 0 | Active |
| US9968643B2 | Selection and use of lactic acid bacteria preventing bone loss in mammals | Chemistry; Metallurgy | 0 | Active |
| US10656141B2 | Selection of agents modulating gastrointestinal pain | Physics | 0 | Active |
| US9816150B2 | Method for selection of agents influencing intestinal motility disorders and pain | Physics | 0 | Active |
| US10143714B2 | In ovo delivery of probiotic cultures | Chemistry; Metallurgy | 0 | Active |
| US10232001B2 | Selection and use of lactic acid bacteria preventing bone loss in mammals | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.